EcoDrugPlus

Mapk Activated Protein Kinase 2

Ensembl ID : ENSFCAG00000013513
Gene Symbol: MAPKAPK2
5 Cross references
240 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSFCAG00000025333
Gene Symbol: MAPKAPK5
5 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 1

Ensembl ID : ENSFCAG00000007999
Gene Symbol: MKNK1
5 Cross references
168 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSFCAG00000012087
Gene Symbol: MKNK2
5 Cross references
221 Possible Orthologues:

Mcl1 Apoptosis Regulator, Bcl2 Family Member

Ensembl ID : ENSFCAG00000030278
Gene Symbol: MCL1
5 Cross references
245 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSFCAG00000024456
Gene Symbol: MDM2
5 Cross references
257 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSFCAG00000009534
Gene Symbol: MET
5 Cross references
207 Possible Orthologues:

Mpl Proto-Oncogene, Thrombopoietin Receptor

Ensembl ID : ENSFCAG00000015112
Gene Symbol: MPL
5 Cross references
186 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSFCAG00000027658
Gene Symbol: MLST8
5 Cross references
202 Possible Orthologues:

Nad(P)h Quinone Dehydrogenase 1

Ensembl ID : ENSFCAG00000029564
Gene Symbol: NQO1
5 Cross references
195 Possible Orthologues:

Nadph Oxidase 4

Ensembl ID : ENSFCAG00000026770
Gene Symbol: NOX4
5 Cross references
150 Possible Orthologues:

Nfe2 Like Bzip Transcription Factor 2

Ensembl ID : ENSFCAG00000012147
Gene Symbol: NFE2L2
5 Cross references
216 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).